Transforming Growth Factor-β

  • Anita B. Roberts
  • Michael B. Sporn


Transforming growth factor-β (TGF-β) is generally acknowledged to be the cytokine with the broadest range of activities in repair of injured tissue, based both on the variety of cell types that produce and/or respond to it and on the spectrum of its cellular responses (Roberts and Sporn, 1990). TGF-β is released from degranulating platelets and secreted by all of the major cell types participating in the repair process, including lymphocytes, macrophages, endothelial cells, smooth muscle cells, epithelial cells, and fibroblasts (see Fig. 1). A unique feature of this molecule is that its autoinduction results in sustained expression at the site of a wound and extends the effectiveness of both the initial burst of endogenous TGF-β released upon injury and exogenous TGF-β that might be applied to a wound. The ability of TGF-β to improve and/or accelerate tissue repair has been studied extensively in a variety of animal models of both normal and impaired healing. A limited number of clinical trials are in progress, but it is anticipated that many new applications for TGF-β will ultimately be found, once problems with appropriate timing and formulation can be solved.


Wound Healing Macular Hole Incisional Wound Wound Fluid Excisional Wound 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams, D. H., Hathaway, M., Shaw, J., Burnett, D., Elias, E., and Strain, A. J., 1991, Transforming growth factor-beta induces human T lymphocyte migration in vitro, J. Immunol. 147:609–612.PubMedGoogle Scholar
  2. Adolph, V. R., DiSanto, S. K., Bleacher, J. C., Dillon, P. W., and Krummel, T. M., 1993, The potential role of the lymphocyte in fetal wound healing, J. Pediatr. Surg. 28:1316–1320.CrossRefPubMedGoogle Scholar
  3. Adzick, N. S., and Harrison, M. R., 1994, Fetal surgical therapy, Lancet 343:897–902.CrossRefPubMedGoogle Scholar
  4. Adzick, N. S., and Lorenz, H. P., 1994, Cells, matrix, growth factors, and the surgeon. The biology of scarless fetal wound repair, Ann. Surg. 220:10–18.CrossRefPubMedGoogle Scholar
  5. Altman, D. J., Schneider, S. L., Thompson, D. A., Cheng, H. L., and Tomasi, T. B., 1990, A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterus, J. Exp. Med. 172:1391–1401.CrossRefPubMedGoogle Scholar
  6. Ammann, A. J., Beck, L. S., DeGuzman, L., Hirabayashi, S. E., Lee, W. P., McFatridge, L., Nguyen, T., Xu, Y., and Mustoe, T. A., 1990, Transforming growth factor-beta. Effect on soft tissue repair, Ann. NY Acad. Sci. 593:124–134.CrossRefPubMedGoogle Scholar
  7. Anderson, D. H., Guerin, C. J., Hageman, G. S., Pfeffer, B. A., and Flanders, K. C., 1995, The distribution of TGF-β isoforms in the mammalian retina, retinal pigment epithelium, and choroid, J. Neurosci. Res. 42:63–79.CrossRefPubMedGoogle Scholar
  8. Anscher, M. S., Crocker, I. R., and Jirtle, R. L., 1990, Transforming growth factor-beta 1 expression in irradiated liver, Radiat. Res. 122:77–85.CrossRefPubMedGoogle Scholar
  9. Armendariz-Borunda, J., Seyer, J. M., Kang, A. H., and Raghow, R., 1990, Regulation of TGF beta gene expression in rat liver intoxicated with carbon tetrachloride, FASEB J. 4:215–221.PubMedGoogle Scholar
  10. Armstead, W. M., Mirro, R., Zuckerman, S. L., Shibata, M., and Leffler, C. W., 1993, Transforming growth factor-beta attenuates ischemia-induced alterations in cerebrovascular responses, Am. J. Physiol. 264:H381–H385.PubMedGoogle Scholar
  11. Bassing, C. H., Yingling, J. M., Howe, D. J., Wang, T., He, W. W., Gustafson, M. L., Shah, P., Donahoe, P. K., and Wang, X. F., 1994, A transforming growth factor beta type I receptor that signals to activate gene expression, Science 263:87–89.CrossRefPubMedGoogle Scholar
  12. Basson, C. T., Kocher, O., Basson, M. D., Asis, A., and Madri, J. A., 1992, Differential modulation of vascular cell integrin and extracellular matrix expression in vitro by TGF-beta 1 correlates with reciprocal effects on cell migration, J. Cell. Physiol. 153:118–128.CrossRefPubMedGoogle Scholar
  13. Beck, L. S., Chen, T. L., Hirabayashi, S. E., DeGuzman, L., Lee, W. P., McFatridge, L. L., Xu, Y., Bates, R. L., and Ammann, A. J., 1990a, Accelerated healing of ulcer wounds in the rabbit ear by recombinant human transforming growth factor-beta 1, Growth Factors 2:273–282.PubMedGoogle Scholar
  14. Beck, L. S., Chen, T. L., Mikalauski, P., and Ammann, A. J., 1990b, Recombinant human transforming growth factor-beta 1 (rhTGF-beta 1) enhances healing and strength of granulation skin wounds, Growth Factors 3:267–275.CrossRefPubMedGoogle Scholar
  15. Beck, L. S., DeGuzman, L., Lee, W. P., Xu, Y., McFatridge, L. A., and Amento, E. P., 1991, TGF-beta 1 accelerates wound healing: Reversal of steroid-impaired healing in rats and rabbits, Growth Factors 5:295–304.CrossRefPubMedGoogle Scholar
  16. Beck, L. S., Amento, E. P., Xu, Y., DeGuzman, L., Lee, W. P., Nguyen, T., and Gillett, N. A., 1993a, TGF-beta 1 induces bone closure of skull defects: Temporal dynamics of bone formation in defects exposed to rhTGF-beta 1, J. Bone Miner. Res. 8:753–761.CrossRefPubMedGoogle Scholar
  17. Beck, L. S., DeGuzman, L., Lee, W. P., Xu, Y., Siegel, M. W., and Amento, E. P., 1993b, One systemic administration of transforming growth factor-beta 1 reverses age-or glucocorticoid-impaired wound healing, J. Clin. Invest. 92:2841–2849.CrossRefPubMedGoogle Scholar
  18. Bernstein, E. F., Harisiadis, L., Salomon, G., Norton, J., Sollberg, S., Uitto, J., Glatstein, E., Glass, J., Talbot, T., Russo, A., and Mitchell, J. B., 1991, Transforming growth factor-beta improves healing of radiation-impaired wounds, J. Invest. Dermatol. 97:430–434.CrossRefPubMedGoogle Scholar
  19. Bonewald, L. F., Wakefield, L., Oreffo, R. O. C., Escobedo, A., Twardzik, D. R., and Mundy, G. R., 1991, Latent forms of transforming growth factor β (TGF-β) derived from bone cultures: Identification of a naturally occurring 100 kDa complex with similarity to recombinant latent TGF-β, Mol. Endocrinol. 5:741–751.CrossRefPubMedGoogle Scholar
  20. Border, W. A., and Noble, N. A., 1994, Transforming growth factor-β in tissue fibrosis: Understanding the molecular basis of fibrotic disease, N. Engl. J. Med. 331:1286–1292.CrossRefPubMedGoogle Scholar
  21. Border, W. A., Okuda, S., Languino, L. R., and Ruoslahti, E., 1990a, Transforming growth factor-beta regulates production of proteoglycans by mesangial cells, Kidney Int. 37:689–695.CrossRefPubMedGoogle Scholar
  22. Border, W. A., Okuda, S., Languino, L. R., Sporn, M. B., and Ruoslahti, E., 1990b, Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1, Nature 346: 371–374.CrossRefPubMedGoogle Scholar
  23. Bornstein, P., 1992, Thrombospondins—structure and regulation of expression, FASEB J. 6:3290–3299.PubMedGoogle Scholar
  24. Brandes, M. E., Mai, U. E., Ohura, K., and Wahl, S. M., 1991, Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta, J. Immunol. 147: 1600–1606.PubMedGoogle Scholar
  25. Broadley, K. N., Aquino, A. M., Hicks, B., Ditesheim, J. A., McGee, G. S., Demetriou, A. A., Woodward, S. C., and Davidson, J. M., 1989, The diabetic rat as an impaired wound healing model: Stimulatory effects of transforming growth factor-beta and basic fibroblast growth factor, Biotechnol. Ther. 1:55–68.PubMedGoogle Scholar
  26. Brown, G. L., Curtsinger, L. J., White, M., Mitchell, R. O., Pietsch, J., Nordquist, R., von Fraunhofer, A., and Schultz, G. S., 1988, Acceleration of tensile strength of incisions treated with EGF and TGF-beta, Ann. Surg. 208:788–794.CrossRefPubMedGoogle Scholar
  27. Brown, P. D., Wakefield, L. M., Levinson, A. D., and Sporn, M. B., 1990, Physicochemical activation of recombinant latent transforming growth factor-beta’s 1, 2, and 3, Growth Factors 3:35–43.CrossRefPubMedGoogle Scholar
  28. Burt, D. W., and Law, A. S., 1994, Evolution of the transforming growth factor-beta superfamily, Prog. Growth Factor Res. 5:99–118.CrossRefPubMedGoogle Scholar
  29. Castilla, A., Prieto, J., and Fausto, N., 1991, Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy, N. Engl. J. Med. 324:933–940.CrossRefPubMedGoogle Scholar
  30. Chen, T. L., Bates, R. L., Xu, Y., Ammann, A. J., and Beck, L. S., 1992, Human recombinant transforming growth factor-beta 1 modulation of biochemical and cellular events in healing of ulcer wounds, J. Invest. Dermatol. 98:428–435.CrossRefPubMedGoogle Scholar
  31. Ciacci, C., Lind, S. E., and Podolsky, D. K., 1993, Transforming growth factor beta regulation of migration in wounded rat intestinal epithelial monolayers, Gastroenterology 105:93–101.PubMedGoogle Scholar
  32. Connor, Jr., T. B., Roberts, A. B., Sporn, M. B., Danielpour, D., Dart, L. L., Michels, R. G., de Bustros, S., Enger, C., Kato, H., Lansing, M., Hayashi, H., and Glaser, B. M., 1989, Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye, J. Clin. Invest. 83:1661–1666.CrossRefPubMedGoogle Scholar
  33. Cox, D. A., Kunz, S., Cerletti, N., McMaster, G. K., and Burk, R. R., 1992, Wound healing in aged animals—Effects of locally applied transforming growth factor beta 2 in different model systems, EXS 61: 287–295.PubMedGoogle Scholar
  34. Cromack, D. T., Sporn, M. B., Roberts, A. B., Merino, M. J., Dart, L. L., and Norton, J. A., 1987, Transforming growth factor beta levels in rat wound chambers, J. Surg. Res. 42:622–628.CrossRefPubMedGoogle Scholar
  35. Cromack, D. T., Pierce, G. F., and Mustoe, T. A., 1991, TGF-beta and PDGF mediated tissue repair: Identifying mechanisms of action using impaired and normal models of wound healing, Prog. Clin. Biol. Res. 365:359–373.PubMedGoogle Scholar
  36. Cromack, D. T., Porras-Reyes, B., Purdy, J. A., Pierce, G. F., and Mustoe, T. A., 1993, Acceleration of tissue repair by transforming growth factor beta 1: Identification of in vivo mechanism of action with radiotherapy-induced specific healing deficits, Surgery 113:36–42.PubMedGoogle Scholar
  37. Curtsinger, L. J., Pietsch, J. D., Brown, G. L., von Fraunhofer, A., Ackerman, D., Polk, Jr., H. C., and Schultz, G. S., 1989, Reversal of adriamycin-impaired wound healing by transforming growth factor-beta, Surg. Gynecol. Obstet. 168:517–522.PubMedGoogle Scholar
  38. Czaja, M. J., Flanders, K. C., Biempica, L., Klein, C., Zern, M. A., and Weiner, F. R., 1989, Expression of tumor necrosis factor-alpha and transforming growth factor-beta 1 in acute liver injury, Growth Factors 1:219–226.CrossRefPubMedGoogle Scholar
  39. Dallas, S. L., Park-Snyder, S., Miyazono, K., Twardzik, D., Mundy, G. R., and Bonewald, L. F., 1994, Characterization and autoregulation of latent transforming growth factor beta (TGF beta) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGF beta-binding protein, J. Biol. Chem. 269:6815–6821.PubMedGoogle Scholar
  40. Danielpour, D., and Sporn, M. B., 1990, Differential inhibition of transforming growth factor beta 1 and beta 2 activity by alpha 2-macroglobulin, J. Biol. Chem. 265:6973–6977.PubMedGoogle Scholar
  41. Dey, B. R., Sukhatme, V. P., Roberts, A. B., Sporn, M. B., Rauscher III, F. J., and Kim, S.-J., 1994, Repression of the transforming growth factor-β1 gene by the Wilms’ tumor suppressor WT1 gene product, Mol. Endocrinol. 8:595–602.CrossRefPubMedGoogle Scholar
  42. Dreizen, S., McCredie, K. B., and Keating, M. J., 1981, Chemotherapy induced mucositis in adult leukemia, Postgrad. Med. 69:103–108.PubMedGoogle Scholar
  43. D’Souza, R. N., Niederreither, K., and de Crombrugghe, B., 1993, Osteoblast-specific expression of the alpha 2(I) collagen promoter in transgenic mice: Correlation with the distribution of TGF-beta 1, J Bone Miner. Res. 8:1127–1136.CrossRefPubMedGoogle Scholar
  44. Dvorak, H. F., 1986, Tumors: Wounds that do not heal, N. Engl. J. Med. 315:1650–1659.CrossRefPubMedGoogle Scholar
  45. Ebner, R., Chen, R. H., Lawler, S., Zioncheck, T., and Derynck, R., 1993, Determination of type I receptor specificity by the type II receptors for TGF-beta or activin, Science 262:900–902.CrossRefPubMedGoogle Scholar
  46. Eklov, S., Funa, K., Nordgren, H., Olofsson, A., Kanzaki, T., Miyazono, K., and Nilsson, S., 1993, Lack of the latent transforming growth factor beta binding protein in malignant, but not benign prostatic tissue, Cancer Res. 53:3193–3197.PubMedGoogle Scholar
  47. Ellis, I., Grey, A. M., Schor, A. M., and Schor, S. L., 1992, Antagonistic effects of TGF-beta 1 and MSF on fibroblast migration and hyaluronic acid synthesis. Possible implications for dermal wound healing, J Cell Sci. 102:447–456.PubMedGoogle Scholar
  48. Falcone, D. J., McCaffrey, T. A., Haimovitz-Friedman, A., Vergilio, J. A., and Nicholson, A. C., 1993, Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation, J. Biol. Chem. 268:11951–11958.PubMedGoogle Scholar
  49. Fawthrop, F. W., Oyajobi, B. O., Bunning, R. A., and Russell, R. G., 1992, The effect of transforming growth factor beta on the plasminogen activator activity of normal human osteoblast-like cells and a human osteosarcoma cell line MG-63, J. Bone Miner. Res. 7:1363–1371.CrossRefPubMedGoogle Scholar
  50. Finch, C. E., Laping, N. J., Morgan, T. E., Nichols, N. R., and Pasinetti, G. M., 1993, TGF-beta 1 is an organizer of responses to neurodegeneration, J. Cell. Biochem. 53:314–322.CrossRefPubMedGoogle Scholar
  51. Finkelstein, J. N., Johnston, C. J., Baggs, R., and Rubin, P., 1994, Early alterations in extracellular matrix and transforming growth factor beta gene expression in mouse lung indicative of late radiation fibrosis, Int. J Radiat. Oncol. Biol. Phys. 28:621–631.CrossRefPubMedGoogle Scholar
  52. Flaumenhaft, R., Abe, M., Sato, Y., Miyazono, K., Harpel, J., Heldin, C. H., and Rifkin, D. B., 1993a, Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells, J. Cell Biol. 120:995–1002.CrossRefPubMedGoogle Scholar
  53. Flaumenhaft, R., Kojima, S., Abe, M., and Rifkin, D. B., 1993b, Activation of latent transforming growth factor beta, Adv. Pharmacol. 24:51–76.CrossRefPubMedGoogle Scholar
  54. Franzén, L. E., and Schultz, G. S., 1993, Transforming growth factor-β enhances connective tissue repair in perforated rat mesentery but not peritoneal macrophage chemotaxis, Wound Rep. Reg. 1:149–55.CrossRefGoogle Scholar
  55. Fukushima, D., Butzow, R., Hildebrand, A., and Rouslahti, E., 1993, Localization of transforming growth factor-β binding site in betaglycan, J. Biol. Chem. 268:22710–22715.PubMedGoogle Scholar
  56. Gajdusek, C. M., Luo, Z., and Mayberg, M. R., 1993, Basic fibroblast growth factor and transforming growth factor beta-1: Synergistic mediators of angiogenesis in vitro, J. Cell. Physiol. 157:133–144.CrossRefPubMedGoogle Scholar
  57. Geiser, A. G., Burmester, J. K., Webbink, R., Roberts, A. B., and Sporn, M. B., 1992, Inhibition of growth by transforming growth factor-beta following fusion of two nonresponsive human carcinoma cell lines. Implication of the type II receptor in growth inhibitory responses, J. Biol. Chem. 267:2588–2593.PubMedGoogle Scholar
  58. Ghahary, A., Shen, Y. J., Scott, P. G., Gong, Y., and Tredget, E. E., 1993, Enhanced expression of mRNA for transforming growth factor-beta, type I and type III procollagen in human post-burn hypertrophic scar tissues, J. Lab. Clin. Med. 122:465–473.PubMedGoogle Scholar
  59. Giri, S. N., Hyde, D. M., and Hollinger, M. A., 1993, Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice, Thorax 48:959–966.CrossRefPubMedGoogle Scholar
  60. Glaser, B. M., Michels, R. G., Kuppermann, B. D., Sjaarda, R. N., and Pena, R. A., 1992, Transforming growth factor-beta 2 for the treatment of full-thickness macular holes. A prospective randomized study, Ophthalmology 99:1162–1172.PubMedGoogle Scholar
  61. Glick, A. B., Abdulkarem, N., Flanders, K. C., Lumadue, J. A., Smith, J. M., and Sporn, M. B., 1991, Complex regulation of TGFβ expression by retinoic acid in the vitamin A-deficient rat, Development 111:1081–1086.PubMedGoogle Scholar
  62. Gombotz, W. R., Pankey, S. C., Bouchard, L. S., Ranchalis, J., and Puolakkainen, P., 1993, Controlled release of TGF-beta 1 from a biodegradable matrix for bone regeneration, J. Biomater. Sci. Polym. Ed. 5:49–63.CrossRefPubMedGoogle Scholar
  63. Graham, M. F., Bryson, G. R., and Diegelmann, R. F., 1990, Transforming growth factor beta 1 selectively augments collagen synthesis by human intestinal smooth muscle cells, Gastroenterology 99:447–453.PubMedGoogle Scholar
  64. Grant, M. B., Khaw, P. T., Schultz, G. S., Adams, J. L., and Shimizu, R. W., 1992, Effects of epidermal growth factor, fibroblast growth factor, and transforming growth factor-beta on corneal cell chemotaxis, Invest. Ophthalmol. Vis. Sci. 33:3292–3301.PubMedGoogle Scholar
  65. Gross, C. E., Bednar, M. M., Howard, D. B., and Sporn, M. B., 1993, Transforming growth factor-beta 1 reduces infarct size after experimental cerebral ischemia in a rabbit model, Stroke 24:558–562.CrossRefPubMedGoogle Scholar
  66. Haddow, A., 1972, Molecular repair, wound healing, and carcinogenesis: Tumor production a possible overhealing? Adv. Cancer Res. 16:181–234.CrossRefPubMedGoogle Scholar
  67. Harpel, J. G., Metz, C. N., Kojima, S., and Rifkin, D. B., 1992, Control of transforming growth factor-beta activity: Latency vs. activation, Prog. Growth Factor. Res. 4:321–335.CrossRefPubMedGoogle Scholar
  68. He, W. W., Gustafson, M. L., Hirobe, S., and Donahoe, P. K., 1993, Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-β type II receptor family, Dev. Dyn. 196:133–142.CrossRefPubMedGoogle Scholar
  69. Hebda, P. A., 1988, Stimulatory effects of transforming growth factor-beta and epidermal growth factor on epidermal cell outgrowth from porcine skin expiant cultures, J. Invest. Dermatol. 91:440–445.CrossRefPubMedGoogle Scholar
  70. Houghton, P. E., Keefer, K. A., and Krummel, T. M., 1995, The role of transforming growth factor beta (TGF-β) in the conversion from scarless healing to healing with scar formation, Wound Rep. Reg. 3:229–236.CrossRefGoogle Scholar
  71. Hunt, T. K., Ehrlich, H. P., Garcia, J. A., and Dunphy, J. E., 1969, Effect of vitamin A on reversing the inhibitory effect of cortisone on healing of open wounds in animals and man, Ann. Surg. 170:633–641.CrossRefPubMedGoogle Scholar
  72. Jampel, H. D., Roche, N., Stark, W. J., and Roberts, A. B., 1990, Transforming growth factor-beta in human aqueous humor, Curr. Eye Res. 9:963–969.CrossRefPubMedGoogle Scholar
  73. Jin, Y., Cox, D. A., Knecht, R., Raschdorf, F., and Cerletti, N., 1991, Separation, purification, and sequence identification of TGF-beta 1 and TGF-beta 2 from bovine milk, J. Protein Chem. 10:565–575.CrossRefPubMedGoogle Scholar
  74. Jones, S. C., Curtsinger, L. J., Whalen, J. D., Pietsch, J. D., Ackerman, D., Brown, G. L., and Schultz, G. S., 1991, Effect of topical recombinant TGF-beta on healing of partial thickness injuries, J. Surg. Res. 51:344–352.CrossRefPubMedGoogle Scholar
  75. Joyce, M. E., Roberts, A. B., Sporn, M. B., and Bolander, M. E., 1990, Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur, J. Cell Biol. 110:2195–2207.CrossRefPubMedGoogle Scholar
  76. Joyce, M. E., Jingushi, S., Scully, S. P., and Bolander, M. E., 1991, Role of growth factors in fracture healing, Prog. Clin. Biol. Res 365:391–416.PubMedGoogle Scholar
  77. Kane, C. J., Hebda, P. A., Mansbridge, J. N., and Hanawalt, P. C., 1991, Direct evidence for spatial and temporal regulation of transforming growth factor beta 1 expression during cutaneous wound healing, J. Cell. Physiol. 148:157–173.CrossRefPubMedGoogle Scholar
  78. Keski-Oja, J., and Koli, K., 1992, Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-beta 1, J. Invest. Dermatol. 99:193–200.CrossRefPubMedGoogle Scholar
  79. Khalil, N., and Greenberg, A. H., 1991, The role of TGF-beta in pulmonary fibrosis, Ciba Found. Symp. 157:194–207.PubMedGoogle Scholar
  80. Khalil, N., Whitman, C., Zuo, L., Danielpour, D., and Greenberg, A., 1993, Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat, J. Clin. Invest. 92:1812–1818.CrossRefPubMedGoogle Scholar
  81. Kim, S. J., Jeang, K. T., Glick, A. B., Sporn, M. B., and Roberts, A. B., 1989, Promoter sequences of the human transforming growth factor-beta 1 gene responsive to transforming growth factor-beta 1 autoin-duction, J. Biol. Chem. 264:7041–7045.PubMedGoogle Scholar
  82. Kim, S. J., Park, K., Koeller, D., Kim, K. Y., Wakefield, L. M., Sporn, M. B., and Roberts, A. B., 1992, Post-transcriptional regulation of the human transforming growth factor-beta 1 gene, J. Biol. Chem. 267: 13702–13707.PubMedGoogle Scholar
  83. Kojima, S., and Rifkin, D. B., 1993, Mechanism of retinoid-induced activation of latent transforming growth factor-beta in bovine endothelial cells, J. Cell. Physiol. 155:323–332.CrossRefPubMedGoogle Scholar
  84. Ksander, G. A., Chu, G. H., McMullin, H., Ogawa, Y., Pratt, B. M., Rosenblatt, J. S., and McPherson, J. M., 1990a, Transforming growth factors-beta 1 and beta 2 enhance connective tissue formation in animal models of dermal wound healing by secondary intent, Ann. NY Acad. Sci. 593:135–147.CrossRefPubMedGoogle Scholar
  85. Ksander, G. A., Ogawa, Y., Chu, G. H., McMullin, H., Rosenblatt, J. S., and McPherson, J. M., 1990b, Exogenous transforming growth factor-beta 2 enhances connective tissue formation and wound strength in guinea pig dermal wounds healing by secondary intent, Ann. Surg. 211:288–294.PubMedGoogle Scholar
  86. Ksander, G. A., Gerhardt, C. O., and Olsen, D. R., 1993, Exogenous transforming growth factor-β2 enhances connective tissue formation in transforming growth factor-β1-deficient, healing-impaired dermal wounds in mice, Wound Rep. Reg. 1:137–148.CrossRefGoogle Scholar
  87. Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., and Karlsson, S., 1993, Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death, Proc. Natl. Acad. Sci. USA 90:770–774.CrossRefPubMedGoogle Scholar
  88. Kulozik, M., Hogg, A., Lankat-Buttgereit, B., and Krieg, T., 1990, Co-localization of transforming growth factor beta 2 with alpha 1(1) procollagen mRNA in tissue sections of patients with systemic sclerosis, J. Clin. Invest. 86:917–922.CrossRefPubMedGoogle Scholar
  89. Lafyatis, R., Lechleider, R., Kim, S. J., Jakowlew, S., Roberts, A. B., and Sporn, M. B., 1990, Structural and functional characterization of the transforming growth factor beta 3 promoter. A cAMP-responsive element regulates basal and induced transcription, J. Biol. Chem. 265:19128–19136.PubMedGoogle Scholar
  90. Lafyatis, R., Lechleider, R., Roberts, A. B., and Sporn, M. B., 1991, Secretion and transcriptional regulation of transforming growth factor-β3 during myogenesis, Mol. Cell Biol. 11.7:3795–3803.PubMedGoogle Scholar
  91. Lansing, M. B., Glaser, B. M., Liss, H., Hanham, A., Thompson, J. T., Sjaarda, R. N., and Gordon, A. J., 1993, The effect of pars plana vitrectomy and transforming growth factor-beta 2 without epiretinal membrane peeling on full-thickness macular holes, Ophthalmology 100:868–871.PubMedGoogle Scholar
  92. Lawrence, W. T., and Diegelmann, R. F., 1994, Growth factors in wound healing, Clin. Dermatol. 12:157–169.CrossRefPubMedGoogle Scholar
  93. Lefer, A. M., Tsao, P., Aoki, N., and Palladino, Jr., M. A., 1990, Mediation of cardioprotection by transforming growth factor-beta, Science 249:61–64.CrossRefPubMedGoogle Scholar
  94. Lefer, A. M., Ma, X. L., Weyrich, A. S., and Scalia, R., 1993, Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion, Proc. Natl. Acad. Sci. USA 90:1018–1022.CrossRefPubMedGoogle Scholar
  95. Levine, J. H., Moses, H. L., Gold, L. I., and Nanney, L. B., 1993, Spatial and temporal patterns of immunoreactive transforming growth factor beta 1, beta 2, and beta 3 during excisional wound repair, Am. J. Pathol. 143:368–380.PubMedGoogle Scholar
  96. Limper, A. H., Colby, T. V., Sanders, M. S., Asakura, S., Roche, P. C., and DeRemee, R. A., 1994, Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granu-lomas of pulmonary sarcoidosis, Am. J. Respir. Crit. Care Med. 149:197–204.CrossRefPubMedGoogle Scholar
  97. Lin, H. Y., and Moustakas, A., 1994, TGF-β receptors: Structure and function, Cell. Mol. Biol. 40:337–349.PubMedGoogle Scholar
  98. Lin, H. Y., Wang, X.-F., Ng-Eaton, E., Weinberg, R. A., and Lodish, H. F., 1992, Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase, Cell 68:775–785.CrossRefPubMedGoogle Scholar
  99. Lindholm, D., Castren, E., Kiefer, R., Zafra, F., and Thoenen, H., 1992, Transforming growth factor-beta 1 in the rat brain: Increase after injury and inhibition of astrocyte proliferation, J. Cell Biol. 117:395–400.CrossRefPubMedGoogle Scholar
  100. Liu, J., Hales, A. M., Chamberlain, C. G., and McAvoy, J. W., 1994, Induction of cataract-like changes in rat lens epithelial expiants by transforming growth factor beta, Invest. Ophthalmol. Vis. Sci. 35:388–401.PubMedGoogle Scholar
  101. Liu, Q., Huang, S.S., and Huang, J. S., 1994, Kinase activity of the type V transforming growth factor beta receptor, J. Biol. Chem. 269:9221–9226.PubMedGoogle Scholar
  102. Logan, A., and Berry, M., 1993, Transforming growth factor-beta 1 and basic fibroblast growth factor in the injured CNS, Trends Pharmacol. Sci. 14:337–342.CrossRefPubMedGoogle Scholar
  103. Logan, A., Frautschy, S. A., Gonzalez, A. M., Sporn, M. B., and Baird, A., 1992, Enhanced expression of transforming growth factor beta 1 in the rat brain after a localized cerebral injury, Brain Res. 587: 216–225.CrossRefPubMedGoogle Scholar
  104. Longaker, M. T., Whitby, D. J., Adzick, N. S., Crombleholme, T. M., Langer, J. C., Duncan, B. W., Bradley, S. M., Stern, R., Ferguson, M. W. J., and Harrison, M. R., 1990, Studies in fetal wound healing. VI. Second and early third trimester fetal wounds demonstrate rapid collagen deposition without scar formation, J. Pediatr. Surg. 25:63–69.CrossRefPubMedGoogle Scholar
  105. Longaker, M. T., Bouhana, K. S., Harrison, M. R., Danielpour, D., Roberts, A. B., and Banda, M. J., 1994, Wound healing in the fetus: Possible role for inflammatory macrophages and transforming growth factor-β isoforms, Wound Rep. Reg. 2:104–112.CrossRefGoogle Scholar
  106. Lynch, S. E., Colvin, R. B., and Antoniades, H. N., 1989, Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds, J. Clin. Invest. 84:640–646.CrossRefPubMedGoogle Scholar
  107. Martin, M., Lefaix, J. L., Pinton, P., Crechet, F., and Daburon, F., 1993, Temporal modulation of TGF-beta 1 and beta-actin gene expression in pig skin and muscular fibrosis after ionizing radiation, Radiat. Res 134:63–70.CrossRefPubMedGoogle Scholar
  108. Martin, P., and Nobes, C. D., 1992, An early molecular component of the wound healing response in rat embryos—induction of c-fos protein in cells at the epidermal wound margin, Mech. Dev. 38:209–215.CrossRefPubMedGoogle Scholar
  109. Martin, P., Hopkinson-Woolley, J., and McCluskey, J., 1992, Growth factors and cutaneous wound repair, Prog. Growth Factor Res. 4:25–44.CrossRefPubMedGoogle Scholar
  110. Martin, P., Dickson, M. C., Millan, F. A., and Akhurst, R. J., 1993, Rapid induction and clearance of TGF beta 1 is an early response to wounding in the mouse embryo, Dev. Genet. 14:225–238.CrossRefPubMedGoogle Scholar
  111. Massagué, J., Attisano, L., and Wrana, J. L., 1994, The TGF-β family and its composite receptors, Trends Cell Biol. 4:172–178.CrossRefPubMedGoogle Scholar
  112. Mast, B. A., Diegelmann, R. F., Krummel, T. M., and Cohen, I. K., 1992, Scarless wound healing in the mammalian fetus, Surg. Gynecol. Obstet. 174:441–451.PubMedGoogle Scholar
  113. McCallion, R., Wood, J., Foreman, D., Shah, M., and Ferguson, M. W. J., 1995, Exogenous mannose-6-phosphate prevents scarring in cutaneous wounds, Laucet, in press.Google Scholar
  114. Merwin, J. R., Anderson, J. M., Kocher, O., Van Itallie, C. M., and Madri, J. A., 1990, Transforming growth factor beta 1 modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis, J. Cell. Physiol. 142:117–128.CrossRefPubMedGoogle Scholar
  115. Miyazono, K., and Heldin, C. H., 1989, Role for carbohydrate structures in TGF-beta 1 latency, Nature 338:158–160.CrossRefPubMedGoogle Scholar
  116. Miyazono, K., Ichijo, H., and Heldin, C. H., 1993, Transforming growth factor-beta: Latent forms, binding proteins and receptors, Growth Factors 8:11–22.CrossRefPubMedGoogle Scholar
  117. Montesano, R., and Orci, L., 1988, Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: Implications for wound healing, Proc. Natl. Acad. Sci. USA 85:4894–4897.CrossRefPubMedGoogle Scholar
  118. Mustoe, T. A., Pierce, G. F., Thomason, A., Gramates, P., Sporn, M. B., and Deuel, T. F., 1987, Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta, Science 237:1333–1336.CrossRefPubMedGoogle Scholar
  119. Mustoe, T. A., Purdy, J., Gramates, P., Deuel, T. F., Thomason, A., and Pierce, G. F., 1989, Reversal of impaired wound healing in irradiated rats by platelet-derived growth factor, Am. J. Surg. 158:345–350.CrossRefPubMedGoogle Scholar
  120. Mustoe, T. A., Landes, A., Cromack, D. T., Mistry, D., Griffin, A., Deuel, T. F., and Pierce, G. F., 1990, Differential acceleration of healing of surgical incisions in the rabbit gastrointestinal tract by platelet-derived growth factor and transforming growth factor, type beta, Surgery 108:324–329.PubMedGoogle Scholar
  121. Mustoe, T. A., Pierce, G. F., Morishima, C., and Deuel, T. F., 1991, Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model, J. Clin. Invest. 87:694–703.CrossRefPubMedGoogle Scholar
  122. Nakamura, T., Miller, D., Ruoslahti, E., and Border, W. A., 1992, Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1, Kidney Int. 41:1213–1221.CrossRefPubMedGoogle Scholar
  123. Nathan, C., and Sporn, M. B., 1991, Cytokines in context, J. Cell Biol. 113:981–986.CrossRefPubMedGoogle Scholar
  124. Nickoloff, B. J., Mitra, R. S., Riser, B. L., Dixit, V. M., and Varani, J., 1988, Modulation of keratinocyte motility. Correlation with production of extracellular matrix molecules in response to growth promoting and antiproliferative factors, Am. J. Pathol. 132:543–551.PubMedGoogle Scholar
  125. Noble, N. A., Harper, J. R., and Border, W. A., 1992, In vivo interactions of TGF-beta and extracellular matrix, Prog. Growth Factor Res. 4:369–382.CrossRefPubMedGoogle Scholar
  126. O’Connor-McCourt, M. D., and Wakefield, L. M., 1987, Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin, J. Biol. Chem. 262:14090–14099.PubMedGoogle Scholar
  127. O’Reilly, M. A., Geiser, A. G., Kim, S. J., Bruggeman, L. A., Luu, A. X., Roberts, A. B., and Sporn, M. B., 1992, Identification of an activating transcription factor (ATF) binding site in the human transforming growth factor-beta 2 promoter, J. Biol. Chem. 267:19938–19943.PubMedGoogle Scholar
  128. Park, K., Kim, S.-J., Bang, Y-J., Park, J.-G., Kim, N. K., Roberts, A. B., and Sporn, M. B., 1994, Genetic change in the transforming growth factor-β (TGF-β) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-β, Proc. Natl. Acad. Sci. USA 91:8772–8776.CrossRefPubMedGoogle Scholar
  129. Peltonen, J., Kähäri, L., Jaakkola, S., Kähäri, V. M., Varga, J., Uitto, J., and Jimenez, S. A., 1990, Evaluation of transforming growth factor beta and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization, J. Invest. Dermatol. 94:365–371.CrossRefPubMedGoogle Scholar
  130. Peltonen, J., Hsiao, L. L., Jaakkola, S., Sollberg, S., Aumailley, M., Timpl, R., Chu, M. L., and Uitto, J., 1991a, Activation of collagen gene expression in keloids: Co-localization of type I and VI collagen and transforming growth factor-beta 1 mRNA, J. Invest. Dermatol. 97:240–248.CrossRefPubMedGoogle Scholar
  131. Peltonen, J., Varga, J., Sollberg, S., Uitto, J., and Jimenez, S. A., 1991b, Elevated expression of the genes for transforming growth factor-beta 1 and type VI collagen in diffuse fasciitis associated with the eosinophilia-myalgia syndrome, J. Invest. Dermatol. 96:20–25.CrossRefPubMedGoogle Scholar
  132. Pepin, M. C., Beauchemin, M., Plamondon, J., and O’Connor-McCourt, M. D., 1994, Mapping of the ligand binding domain of the transforming growth factor β receptor type III by deletion mutagenesis, Proc. Natl. Acad. Sci. USA 91:6997–7001.CrossRefPubMedGoogle Scholar
  133. Pepper, M. S., Vassalli, J. D., Orci, L., and Montesano, R., 1993, Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis, Exp. Cell Res. 204:356–363.CrossRefPubMedGoogle Scholar
  134. Perry, L. C., Connors, A. W., Matrisian, L. M., Nanney, L. B., Charles, D. P., Reyes, D. P., Kerr, L. D., and Fisher, J., 1993, Role of transforming growth factor-β1 and epidermal growth factor in the wound-healing process: An in vivo biomechanical evaluation, Wound Rep. Reg. 1:41–46.CrossRefGoogle Scholar
  135. Pfeilschifter, J., Wolf, O., Naumann, A., Minne, H. W., Mundy, G. R., and Ziegler, R., 1990, Chemotactic response of osteoblastlike cells to transforming growth factor beta, J. Bone Miner. Res. 5:825–830.CrossRefPubMedGoogle Scholar
  136. Phillips, G. D., Whitehead, R. A., and Knighton, D. R., 1992, Inhibition by methylprednisolone acetate suggests an indirect mechanism for TGF-B induced angiogenesis, Growth Factors 6:77–84.CrossRefPubMedGoogle Scholar
  137. Pierce, G. F., Mustoe, T. A., Lingelbach, J., Masakowski, V. R., Gramates, P., and Deuel, T. F., 1989a, Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: Possible regulation in macrophages by platelet-derived growth factor, Proc. Natl. Acad. Sci. USA 86:2229–2233.CrossRefPubMedGoogle Scholar
  138. Pierce, G. F., Mustoe, T. A., Lingelbach, J., Masakowski, V. R., Griffin, G. L., Senior, R. M., and Deuel, T. F., 1989b, Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms, J. Cell Biol. 109:429–440.CrossRefPubMedGoogle Scholar
  139. Pierce, G. F., Brown, D., and Mustoe, T. A., 1991a, Quantitative analysis of inflammatory cell influx, procollagen type I synthesis, and collagen cross-linking in incisional wounds: Influence of PDGF-BB and TGF-beta 1 therapy, J. Lab. Clin. Med. 117:373–382.PubMedGoogle Scholar
  140. Pierce, G. F., Vande Berg, J., Rudolph, R., Tarpley, J., and Mustoe, T. A., 1991b, Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds, Am. J. Pathol. 138:629–646.PubMedGoogle Scholar
  141. Pierce, G. F., Tarpley, J. E., Yanagihara, D., Mustoe, T. A., Fox, G. M., and Thomason, A., 1992, Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair, Am. J. Pathol. 140:1375–1388.PubMedGoogle Scholar
  142. Postlethwaite, A. E., Keski-Oja, J., Moses, H. L., and Kang, A. H., 1987, Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta, J. Exp. Med. 165:251–256.CrossRefPubMedGoogle Scholar
  143. Prehn, J. H., Backhauss, C., and Krieglstein, J., 1993, Transforming growth factor-beta 1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischémie injury in vivo, J. Cereb. Blood Flow Metab. 13:521–525.CrossRefPubMedGoogle Scholar
  144. Quaglino, Jr., D., Nanney, L. B., Kennedy, R., and Davidson, J. M., 1990, Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin. I. Excisional wound model, Lab. Invest. 63:307–319.PubMedGoogle Scholar
  145. Quaglino, Jr., D., Nanney, L. B., Ditesheim, J. A., and Davidson, J. M., 1991, Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin: Incisional wound model, J. Invest. Dermatol. 97:34–42.PubMedGoogle Scholar
  146. Roberts, A. B., and Sporn, M. B., 1990, The transforming growth factor βs, in: Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors, 95th ed. (M. B. Sporn and A. B. Roberts, eds.), pp. 419–472, Springer-Verlag, New York.CrossRefGoogle Scholar
  147. Roberts, A. B., and Sporn, M. B., 1992a, Differential expression of the TGF-beta isoforms in embryogenesis suggests specific roles in developing and adult tissues, Mol. Reprod. Dev. 32:91–98.CrossRefPubMedGoogle Scholar
  148. Roberts, A. B., and Sporn, M. B., 1992b, Mechanistic Interrelationships between two superfamilies: The steroid/retinoid receptors and transforming growth factor-β, Cancer Surv. 14:205–219.PubMedGoogle Scholar
  149. Roberts, A. B., and Sporn, M. B., 1993, Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta), Growth Factors 8:1–9.CrossRefPubMedGoogle Scholar
  150. Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V., Kehrl, J. H., and Fauci, A. S., 1986, Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro, Proc. Natl. Acad. Sci. USA 83:4167–4171.CrossRefPubMedGoogle Scholar
  151. Roberts, A. B., Rosa, F., Roche, N. S., Coligan, J. E., Garfield, M., Rebbert, M. L., Kondaiah, P., Danielpour, D., Kehrl, J. H., Wahl, S. M., David, I. B., and Sporn, M. B., 1990, Isolation and characterization of TGF-beta 2 and TGF-beta 5 from medium conditioned by Xenopus XTC cells, Growth Factors 2: 135–147.CrossRefPubMedGoogle Scholar
  152. Roberts, A. B., Sporn, M. B., and Lefer, A. M., 1993, Cardioprotective actions of transforming growth factor-β, Trends Cardiol. Med. 3:77–81.CrossRefGoogle Scholar
  153. Robson, M. C., Phillips, L. G., Cooper, D. M., Robson, L. E., Hanham, A. F., and Ksander, G. A., 1995, Transforming growth factor-β2 accelerates healing of venous stasis ulcers in an open-label, placebo-controlled clinical study, Wound Rep. Reg., 3:157–167.CrossRefGoogle Scholar
  154. Romeo, D. S., Park, K., Roberts, A. B., Sporn, M. B., and Kim, S. J., 1993, An element of the transforming growth factor-beta 1 5’-untranslated region represses translation and specifically binds a cytosolic factor, Mol Endocrinol. 7:759–766.CrossRefPubMedGoogle Scholar
  155. Salomon, G. D., Kasid, A., Bernstein, E., Buresh, C., Director, E., and Norton, J. A., 1990, Gene expression in normal and doxorubicin-impaired wounds: Importance of transforming growth factor-beta, Surgery 108:318–322.PubMedGoogle Scholar
  156. Sato, Y., and Rifkin, D. B., 1989, Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture, J. Cell Biol. 109:309–315.CrossRefPubMedGoogle Scholar
  157. Schmid, P., Cox, D., Bilbe, G., McMaster, G., Morrison, C., Stahelin, H., Luscher, N., and Seiler, W., 1993a, TGF-beta S and TGF-beta type II receptor in human epidermis: Differential expression in acute and chronic skin wounds, J. Pathol. 171:191–197.CrossRefPubMedGoogle Scholar
  158. Schmid, P., Kunz, S., Cerletti, N., McMaster, G., and Cox, D., 1993b, Injury induced expression of TGF-beta 1 mRNA is enhanced by exogenously applied TGF-beta S, Biochem. Biophys. Res Commun. 194: 399–406.CrossRefPubMedGoogle Scholar
  159. Schuh, A. C., Keating, S. J., Monteclaro, F. S., Vogt, P. K., and Breitman, M. L., 1990, Obligatory wounding requirement for tumorigenesis in v-jun transgenic mice, Nature 346:756–760.CrossRefPubMedGoogle Scholar
  160. Schultz, G., Chegini, N., Grant, M., Khaw, P., and MacKay, S., 1992, Effects of growth factors on corneal wound healing, Acta Ophthalmol. Suppl. 202:60–66.PubMedGoogle Scholar
  161. Schultz-Cherry, S., and Murphy-Ulrich, J. E., 1993, Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism, J. Cell Biol. 122:923–932.CrossRefPubMedGoogle Scholar
  162. Shah, M., Foreman, D. M., and Ferguson, M. W., 1992, Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta, Lancet 339:213–214.CrossRefPubMedGoogle Scholar
  163. Shah, M., Roberts, A. B., Gold, L. I., and Ferguson, M. W. J., 1993, Immunolocalization of TGF-β isoforms in normal and experimentally modulated incisional wounds in adult rodents, Wound Rep. Reg. 1:124.Google Scholar
  164. Shah, M., Foreman, D. M., and Ferguson, W. J., 1994a, Neutralizing antibody to TGF-β 1,2 reduces cutaneous scarring in adult rodents, J. Cell Sci. 107:1137–1157.PubMedGoogle Scholar
  165. Shah, M., Foreman, D. M., and Ferguson, W. J., 1995, Neutralization of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring, J. Cell Sci., 108:985–1002.PubMedGoogle Scholar
  166. Sieweke, M. H., Thompson, N. L., Sporn, M. B., and Bissell, M. J., 1990, Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta, Science 248:1656–1660.CrossRefPubMedGoogle Scholar
  167. Sippola-Thiele, M., Hanahan, D., and Howley, P. M., 1989, Cell-heritable stages of tumor progression in transgenic mice harboring the bovine papillomavirus type 1 genome, Mol. Cell. Biol. 9:925–934.PubMedGoogle Scholar
  168. Slavin, J., Nash, J. R., and Kingsnorth, A. N., 1992, Effect of transforming growth factor beta and basic fibroblast growth factor on steroid-impaired healing intestinal wounds, Br. J. Surg. 79:69–72.CrossRefPubMedGoogle Scholar
  169. Smiddy, W. E., Glaser, B. M., Green, W. R., Connor, Jr., T. B., Roberts, A. B., Lucas, R., and Sporn, M. B., 1989, Transforming growth factor beta. A biologic chorioretinal glue, Arch. Ophthalmol. 107:577–580.CrossRefPubMedGoogle Scholar
  170. Smiddy, W. E., Glaser, B. M., Thompson, J. T., Sjaarda, R. N., Flynn, Jr., H. W., Hanham, A., and Murphy, R. P., 1993, Transforming growth factor-beta 2 significantly enhances the ability to flatten the rim of subretinal fluid surrounding macular holes. Preliminary anatomic results of a multicenter prospective randomized study, Retina 13:296–301.CrossRefPubMedGoogle Scholar
  171. Sodek, J., and Overall, C. M., 1992, Matrix metalloproteinases in periodontal tissue remodelling, Matrix Suppl 1:352–362.PubMedGoogle Scholar
  172. Sonis, S. T., Lindquist, L., Van Vugt, A., Stewart, A. A., Stam, K., Qu, G. Y., Iwata, K. K., and Haley, J. D., 1994, Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta 3, Cancer Res. 54:1135–1138.PubMedGoogle Scholar
  173. Sporn, M. B., and Roberts, A. B., 1993, A major advance in the use of growth factors to enhance wound healing, J. Clin. Invest. 92:2565–2566.CrossRefPubMedGoogle Scholar
  174. Sporn, M. B., Roberts, A. B., Shull, J. H., Smith, J. M., Ward, J. M., and Sodek, J., 1983, Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo, Science 219:1329–1331.CrossRefPubMedGoogle Scholar
  175. Streuli, C. H., Schmidhauser, C., Kobrin, M., Bissell, M. J., and Derynck, R., 1993, Extracellular matrix regulates expression of the TGF-beta 1 gene, J. Cell Biol. 120:253–260.CrossRefPubMedGoogle Scholar
  176. Taipale, J., Koli, K., and Keski-Oja, J., 1992, Release of transforming growth factor-beta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin, J. Biol. Chem. 267:25378–25384.PubMedGoogle Scholar
  177. Taipale, J., Miyazono, K., Heldin, C. H., and Keski-Oja, J., 1994, Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein, J. Cell Biol. 124: 171–181.CrossRefPubMedGoogle Scholar
  178. Taniguchi, Y., Tanaka, T., Gotoh, K., Satoh, R., and Inazu, M., 1993, Transforming growth factor beta 1-induced cellular heterogeneity in the periosteum of rat parietal bones, Calcif. Tissue Int. 53:122–126.CrossRefPubMedGoogle Scholar
  179. ten Dijke, P., Hansen, P., Iwata, K. K., Pieler, C., and Foulkes, J. G., 1988, Identification of another member of the transforming growth factor type β gene family, Proc. Natl. Acad. Sci. USA 85:4715–4719.CrossRefPubMedGoogle Scholar
  180. ten Dijke, P., Franzen, P., Yamashita, H., Ichijo, H., Heldin, C.-H., and Miyazono, K., 1994a, Serine/threonine kinase receptors, Prog. Growth Factor Res. 5:55–72.CrossRefPubMedGoogle Scholar
  181. ten Dijke, P., Yamashita, H., Ichijo, H., Franzen, P., Laiho, M., Miyazono, K., and Heldin, C. H., 1994b, Characterization of type I receptors for transforming growth factor-beta and activin, Science 264: 101–104.CrossRefPubMedGoogle Scholar
  182. Terrell, T. G., Working, P. K., Chow, C. P., and Green, J. D., 1993, Pathology of recombinant human transforming growth factor-beta 1 in rats and rabbits, Int. Rev. Exp. Pathol. 34(Pt B):43–67.PubMedGoogle Scholar
  183. Thomas, G. R., and Thibodaux, H., 1992, Transforming growth factor-beta 1 inhibits postischemic increases in splanchnic vascular resistance, Biotechnol. Ther. 3:91–100.PubMedGoogle Scholar
  184. Tsunawaki, S., Sporn, M., Ding, A., and Nathan, C., 1988, Deactivation of macrophages by transforming growth factor-beta, Nature 334:260–262.CrossRefPubMedGoogle Scholar
  185. Varani, J., Jones, J., Dame, M., Sulavik, C., Gibbs, D. F., and Johnson, K. J., 1991, Effects of all-trans retinoic acid on neutrophil-mediated endothelial cell injury in vitro and immune complex injury in rats, Am. J. Pathol. 139:901–909.PubMedGoogle Scholar
  186. Vodovotz, Y., Bogdan, C., Paik, J., Xie, Q. W., and Nathan, C., 1993, Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta, J. Exp. Med. 178:605–613.CrossRefPubMedGoogle Scholar
  187. Vollberg, T. M., George, M. D., and Jetten, A. M., 1991, Induction of extracellular matrix gene expression in normal human keratinocytes by transforming growth factor beta is altered by cellular differentiation, Exp. Cell Res. 193:93–100.CrossRefPubMedGoogle Scholar
  188. Wahl, S. M., 1989, Glucocorticoids and wound healing, in: Antiinflammatory Steroid Action: Basic and Clinical Aspects (R. P. Schleimer, H. N. Claman, and A. L. Oronsky, eds.), pp. 280–302, Academic Press, New York.Google Scholar
  189. Wahl, S. M., Hunt, D. A., Wakefield, L. M., McCartney-Francis, N., Wahl, L. M., Roberts, A. B., and Sporn, M. B., 1987, Transforming growth factor type beta induces monocyte chemotaxis and growth factor production, Proc. Natl. Acad. Sci. USA 84:5788–5792.CrossRefPubMedGoogle Scholar
  190. Wang, J. Y., and Johnson, L. R., 1994, Expression of protooncogenes c-fos and c-myc in healing of gastric mucosal stress ulcers, Am. J. Physiol. 266:G878–886.PubMedGoogle Scholar
  191. Weinzweig, J., Levenson, S. M., Rettura, G., Weinzweig, N., Mendecki, J., Chang, T. H., and Seifter, E., 1990, Supplemental vitamin A prevents the tumor-induced defect in wound healing, Ann. Surg. 211:269–276.PubMedGoogle Scholar
  192. Whitby, D. J., and Ferguson, M. W. J., 1991a, The extracellular matrix of lip wounds in fetal, neonatal and adult mice, Development 112:651–668.PubMedGoogle Scholar
  193. Whitby, D. J., and Ferguson, M. W., 1991b, Immunohistochemical localization of growth factors in fetal wound healing, Dev. Biol. 147:207–215.CrossRefPubMedGoogle Scholar
  194. Wiessner, C., Gehrmann, J., Lindholm, D., Topper, R., Kreutzberg, G. W., and Hossmann, K. A., 1993, Expression of transforming growth factor-beta 1 and interleukin-1 beta mRNA in rat brain following transient forebrain ischemia, Acta Neuropathol. (Berl) 86:439–446.CrossRefGoogle Scholar
  195. Wikner, N. E., Elder, J. T., Persichitte, K. A., Mink, P., and Clark, R. A., 1990, Transforming growth factor-beta modulates plasminogen activator activity and plasminogen activator inhibitor type-1 expression in human keratinocytes in vitro, J. Invest, Dermatol. 95:607–613.CrossRefGoogle Scholar
  196. Williams, R. S., Rossi, A. M., Chegini, N., and Schultz, G., 1992, Effect of transforming growth factor beta on postoperative adhesion formation and intact peritoneum, J. Surg. Res. 52:65–70.CrossRefPubMedGoogle Scholar
  197. Wysocki, A. B., Staiano-Coico, L., and Grinnell, F., 1993, Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9, J. Invest. Dermatol. 101:64–68.CrossRefPubMedGoogle Scholar
  198. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massagué, J., 1994, Mechanism of activation of the TGF-β receptor, Nature 370:341–347.CrossRefPubMedGoogle Scholar
  199. Yamamoto, T., Nakamura, T., Noble, N. A., Ruoslahti, E., and Border, W. A., 1993, Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy, Proc. Natl. Acad. Sci. USA 90:1814–1818.CrossRefPubMedGoogle Scholar
  200. Yamashita, H., Ichijo, H., Grimsby, S., Moren, A., ten Dijke, P., and Miyazono, K., 1994a, Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-beta, J. Biol. Chem. 269:1995–2001.PubMedGoogle Scholar
  201. Yamashita, H., ten Dijke, P., Franzen, P., Miyazono, K., and Heldin, C.-H., 1994b, Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β, J. Biol. Chem. 269:20172–20178.PubMedGoogle Scholar
  202. Yoshioka, K., Takemura, T., Murakami, K., Okada, M., Hino, S., Miyamoto, H., and Maki, S., 1993, Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys, Lab. Invest. 68:154–163.PubMedGoogle Scholar
  203. Zioncheck, T. F., Chen, S. A., Richardson, L., Mora-Worms, M., Lucas, C., Lewis, D., Green, J. D., and Mordenti, J., 1994, Pharmacokinetics and tissue distribution of recombinant transforming growth fac-tor-β1 after topical and intravenous administration in male rats, Pharm. Res. 11:213–220.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Anita B. Roberts
    • 1
  • Michael B. Sporn
    • 1
  1. 1.Laboratory of ChemopreventionNational Cancer InstituteBethesdaUSA

Personalised recommendations